Profiles of HAV-specific IgA production in mucosal immune response to vaccination.
Yan Gao
Qiudong Su
Yao Yi
Zhiyuan Jia
Hao Wang
Xuexin Lu
Feng Qiu
Shengli Bi
10.1371/journal.pone.0123400.g003
https://plos.figshare.com/articles/figure/_Profiles_of_HAV_specific_IgA_production_in_mucosal_immune_response_to_vaccination_/1377350
<p>HAV IgA was detected by indirect ELISA in (A) vaginal secretions, (B) intestine, (C) respiratory tract and (D) stool homogenates of the mouse groups immunized as indicated in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0123400#pone.0123400.g002" target="_blank">Fig 2</a>. Each serum effective dose (presented as the GMT) is the reciprocal value of the maximum positive dilution. Error bars represent the SEM. *, <i>P</i><0.05, **, <i>P</i><0.01, ***, <i>P</i><0.001; ns, no significant difference.</p>
2015-04-13 05:01:01
hepatitis
protein vaccine
hepatitis E virus
hav
Candidate Mucosal Vaccine
sequence
Hepatitis E Virus Structural Proteins
ifn
E infection
orf
cpg
Enhanced Mucosal Immune Responses Induced
odn
hev
reading frame 2
balb
tuftsin group
tuftsin
aa
mucosal candidate vaccine
virus protein 1
Th 1 response
intranasally
vp